{"id":"https://openalex.org/W76687339","doi":null,"title":"Cyclophosphamide Treatment of MS: Current Therapeutic Approaches and Treatment Regimens.","display_name":"Cyclophosphamide Treatment of MS: Current Therapeutic Approaches and Treatment Regimens.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W76687339","mag":"76687339","pmid":"https://pubmed.ncbi.nlm.nih.gov/20663416"},"language":"en","primary_location":{"id":"pmid:20663416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20663416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International MS journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078716233","display_name":"A I Elkhalifa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"As Elkhalifa","raw_affiliation_strings":["Partners Multiple Sclerosis Center, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Partners Multiple Sclerosis Center, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109316511","display_name":"Weiner Hl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hl Weiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3414,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.79199622,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"17","issue":"1","first_page":"12","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8669999837875366},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/pulse-therapy","display_name":"pulse therapy","score":0.7260000109672546},{"id":"https://openalex.org/keywords/pediatric-multiple-sclerosis","display_name":"pediatric multiple sclerosis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.9179999828338623},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.796999990940094},{"id":"https://openalex.org/keywords/anti-inflammatory-cytokines","display_name":"anti-inflammatory cytokines","score":0.9309999942779541},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/treatment-regimens","display_name":"treatment regimens","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9062543511390686},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.8594278693199158},{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.7961820363998413},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.6339143514633179},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.569436252117157},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.47274526953697205},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4611634612083435},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45389223098754883},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.4343101680278778},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40290433168411255},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3229343295097351},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0799926221370697}],"mesh":[{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008181","descriptor_name":"Lupus Nephritis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:20663416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20663416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International MS journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1545727386","https://openalex.org/W1888641509","https://openalex.org/W1967949675","https://openalex.org/W1969554567","https://openalex.org/W1972663088","https://openalex.org/W1983201310","https://openalex.org/W1984932580","https://openalex.org/W1987961573","https://openalex.org/W1990864893","https://openalex.org/W1995566406","https://openalex.org/W1998455368","https://openalex.org/W2011211944","https://openalex.org/W2018493462","https://openalex.org/W2026218766","https://openalex.org/W2033616268","https://openalex.org/W2034302067","https://openalex.org/W2049831025","https://openalex.org/W2051609512","https://openalex.org/W2052416007","https://openalex.org/W2054010811","https://openalex.org/W2060485000","https://openalex.org/W2061885672","https://openalex.org/W2070656641","https://openalex.org/W2071284269","https://openalex.org/W2079242778","https://openalex.org/W2083774073","https://openalex.org/W2090107811","https://openalex.org/W2119308919","https://openalex.org/W2149638244","https://openalex.org/W2154048571","https://openalex.org/W2155502276","https://openalex.org/W2419506735"],"related_works":["https://openalex.org/W2051609512","https://openalex.org/W1444065442","https://openalex.org/W1990864893","https://openalex.org/W2142311493","https://openalex.org/W2011375891","https://openalex.org/W192855018","https://openalex.org/W76648013","https://openalex.org/W2155222127","https://openalex.org/W78229042","https://openalex.org/W2094701397"],"abstract_inverted_index":{"Immunosuppression":[0],"and":[1,15,43,70,84],"immunotherapy":[2],"have":[3,88],"developed":[4,90],"as":[5,79,173],"the":[6,24,31,61,65,71,92,151],"primary":[7,137],"mode":[8],"of":[9,23,33,41,67,73,94,142,153],"therapy":[10,102,175],"for":[11,35,189],"multiple":[12],"sclerosis":[13],"(MS)":[14],"are":[16,186],"most":[17,127],"effective":[18],"in":[19,30,53,96,109,136,150,167,176],"active,":[20],"relapsing":[21,168],"stages":[22,141],"disease.":[25],"Cyclophosphamide":[26,56,117,164],"has":[27,50,57,118,131],"been":[28,51,89,120],"used":[29,108,121,166],"treatment":[32],"MS":[34,48,145,172],"over":[36],"40":[37],"years.":[38],"The":[39],"effectiveness":[40],"cyclophosphamide":[42,95,130],"its":[44],"ability":[45],"to":[46,106,112,122,179],"stabilize":[47],"patients":[49,177],"suggested":[52],"many":[54],"studies.":[55],"selective":[58],"effects":[59],"on":[60,160],"immune":[62],"response,":[63],"including":[64],"suppression":[66],"Th1/Th17":[68],"responses":[69],"enhancement":[72],"cells":[74],"secreting":[75],"anti-inflammatory":[76],"cytokines":[77],"such":[78],"interleukin":[80],"(IL)":[81],"IL-4,":[82],"IL-10":[83],"TGF-b.":[85],"Different":[86],"regimens":[87],"fosssssssssr":[91],"use":[93],"MS,":[97,139],"from":[98],"intermittent":[99],"outpatient":[100],"pulse":[101],"that":[103],"is":[104,165],"analogous":[105],"protocols":[107],"lupus":[110],"nephritis,":[111],"very":[113],"high-dose":[114],"inpatient":[115],"regimens.":[116],"also":[119],"treat":[123],"paediatric":[124],"MS.":[125],"Like":[126],"immunomodulatory":[128],"drugs,":[129],"limited,":[132],"if":[133],"any":[134],"efficacy":[135],"progressive":[138,144,171],"or":[140,155,169,182],"secondary":[143],"with":[146],"slow":[147],"clinical":[148],"deterioration,":[149],"absence":[152],"relapses":[154],"inflammatory":[156],"changes":[157],"(gadolinium":[158],"enhancement)":[159],"magnetic":[161],"resonance":[162],"imaging.":[163],"actively":[170],"second-line":[174],"unresponsive":[178],"interferon":[180],"beta":[181],"glatiramer":[183],"acetate":[184],"who":[185],"not":[187],"candidates":[188],"natalizumab.":[190]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}